The review was led by Prof. Zvi Loewy, from the Touro College of Pharmacy in New York, NY. It is published in the #journal
The researchers note that #medical #marijuana has been approved in various U.S. states to treat symptoms of #cancer, #HIV/#AIDS, glaucoma, chronic pain, seizures, cachexia, and multiple sclerosis.
Recently, another study suggested that tetrahydrocannabinol (THC) - the active compound in marijuana - reduced beta-amyloid levels in nerve cells, a protein considered a hallmark of #Alzheimersdisease.
In the U.S., Parkinson's disease (PD) affects about 1 million people. It is progressive, which means it gets worse over time, and it occurs when a person's #brain stops producing dopamine.
#Dopamine is a #neurotransmitter that plays a key role in movement as well as in cognitive and #psychological functions.
There is currently no cure for the disease; treatments carry with them several limitations and do not slow progression of #PD.
The researchers from this latest study say recent research has indicated that the endocannabinoid system plays an important role in PD. In detail, components of this system "are highly expressed in the neural circuit of basal ganglia, which is part of a complex neuronal system," they say.